Human CD314 Antibody Conjugated to FITC

<strong>Human CD314 Antibody Conjugated to FITC</strong>_x000D_ <strong>Catalog number:</strong> B2014711_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Human CD314 Antibody (FITC Conjugate)_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Martin TC, Ilieva KM, Visconti A, Beaumont M, Kiddle SJ, Dobson RJB, Mangino M, Lim EM, Pezer M, Steves CJ, Bell JT, Wilson SG, Lauc G, Roederer M, Walsh JP, Spector TD, Karagiannis SN. Dysregulated Antibody, Natural Killer Cell and Immune Mediator Profiles in Autoimmune Thyroid Diseases Cells. 2020 Mar 9;9(3):665._x000D_ 2: Gershtein ES, Mochalova AS, Korotkova EA, Samoilova EV, Vashketova OI, Kuz'min YB, Sokolov NY, Kushlinskii NE. Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1 Bull Exp Biol Med. 2023 Aug;175(4):481-486._x000D_ 3: Breman E, Demoulin B, Agaugué S, Mauën S, Michaux A, Springuel L, Houssa J, Huberty F, Jacques-Hespel C, Marchand C, Marijsse J, Nguyen T, Ramelot N, Violle B, Daro D, De Waele P, Gilham DE, Steenwinckel V. Overcoming Target Driven Fratricide for T Cell Therapy Front Immunol. 2018 Dec 12;9:2940._x000D_ 4: Kim HS, Long EO. Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells Sci Signal. 2012 Jul 10;5(232):ra49._x000D_ 5: Schepis D, Gunnarsson I, Eloranta ML, Lampa J, Jacobson SH, Kärre K, Berg L. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus Immunology. 2009 Jan;126(1):140-6._x000D_ 6: Warren HS. The Eighth Human Leucocyte Differentiation Antigen (HLDA8) Workshop: natural killer cell section report Cell Immunol. 2005 Jul-Aug;236(1-2):17-20._x000D_ 7: Warren HS. The Eighth Human Leucocyte Differentiation Antigen (HLDA8) Workshop: natural killer cell section report Cell Immunol. 2005 Jul-Aug;236(1-2):17-20._x000D_ 8: Zekri AN, El Deeb S, Bahnassy AA, Badr AM, Abdellateif MS, Esmat G, Salama H, Mohanad M, El-Dien AE, Rabah S, Abd Elkader A. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions World J Gastroenterol. 2018 Mar 21;24(11):1228-1238._x000D_ 9: Ning H, Lei HE, Xu YD, Guan RL, Venstrom JM, Lin G, Lue TF, Xin Z, Lin CS. Conversion of adipose-derived stem cells into natural killer-like cells with anti-tumor activities in nude mice PLoS One. 2014 Aug 27;9(8):e106246._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/28721573">10: Müller L, Steiner SK, Rodriguez-Lorenzo L, Petri-Fink A, Rothen-Rutishauser B, Latzin P. Exposure to silver nanoparticles affects viability and function of natural killer cells, mostly via the release of ions Cell Biol Toxicol. 2018 Jun;34(3):167-176. </a>_x000D_ _x000D_ <strong>Products Related to Human CD314 Antibody Conjugated to FITC can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>